RTW — RTW Biotech Opportunities Balance Sheet
0.000.00%
Last trade - 00:00- $407.19m
- $496.98m
- $8.19m
Annual balance sheet for RTW Biotech Opportunities, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.55 | 6.48 | 6.97 | 2.72 | 5.36 |
| Net Total Receivables | 20.7 | 12.5 | 22.6 | 57.9 | 32.2 |
| Long Term Investments | |||||
| Total Other Assets | |||||
| Total Assets | 421 | 439 | 402 | 446 | 760 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.29 | 52 | 53.6 | 17.2 | 127 |
| Other Equity | |||||
| Total Equity | 413 | 387 | 348 | 429 | 633 |
| Total Liabilities & Shareholders' Equity | 421 | 439 | 402 | 446 | 760 |
| Total Common Shares Outstanding |